The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...
Immunovia AB (FRA:1YR) marks a pivotal shift with the Pancreassure test launch, despite challenges in securing widespread insurance coverage.
Objective To develop and validate a 10-year predictive model for cardiovascular and metabolic disease (CVMD) risk using ...
A team of researchers at IOCB Prague headed by Dr. Tomáš Slanina has developed a new method for labeling molecules with ...
Individual prediction uncertainty is a key aspect of clinical prediction model performance; however, standard performance ...
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...
Respiratory medicine has witnessed substantial progress with the introduction of advanced lung function tests, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback